Xcout Intel
CHIMERIX INC
Chimerix, Inc. is a biopharmaceutical company that develops medicines for oncology and other critical illnesses, serving US-based healthcare audiences and patients.
Subscribe to see CHIMERIX INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CHIMERIX INC at a glance
CHIMERIX INC is a biopharmaceuticals company headquartered in United States. It has raised at least $64.9M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round, Series D, raised $30M in April 2025. Xcout tracks 1 named person at CHIMERIX INC, including George Painter (president and CEO).
CHIMERIX INC leadership
- George Painterpresident and CEO
CHIMERIX INC funding rounds
At least $64.9M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $30M | 5 named | |
| SEC Form D filing | $34.9M | — | |
| Grant | Undisclosed | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
CHIMERIX INC competitors
A few of CHIMERIX INC's closest competitors — see the full list of competitors and alternatives →
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Achaogen Inc was a biopharmaceutical company headquartered in South San Francisco, California. The company focused on discovering, developing, and commercializing novel antibacterial treatments.
Cidara Therapeutics, Inc. is a biotechnology company focused on developing late-phase antiviral and immunotherapy agents, with operations based in San Diego, California and Rahway, New Jersey.
ChemoCentryx, Inc. is a biopharmaceutical company with its corporate headquarters and principal place of business located in California.
Citius Oncology is a biopharmaceutical company that develops and commercializes targeted oncology therapies. It serves patients with cancer, including its FDA-approved targeted immune therapy LYMPHIR for cutaneous T-cell lymphoma.
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Get CHIMERIX INC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CHIMERIX INC in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access